Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
onatasertib (ATG-008)
i
Other names:
ATG-008, CC-223, TORKi, CC 223
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Antengene, BMS
Drug class:
mTORC1 inhibitor, mTORC2 inhibitor
Related drugs:
‹
PF-05212384 (31)
CB-228 (29)
nanoparticle albumin-bound rapamycin (10)
MTI-31 (4)
RapaLink-1 (3)
AVTX-006 (2)
SBI-756 (2)
RMC-5552 (1)
SBI-726 (1)
WYE-125132 (0)
XP-105 (0)
AZD2014 (4)
Torin1 (2)
PP242 (2)
PF-05212384 (31)
CB-228 (29)
nanoparticle albumin-bound rapamycin (10)
MTI-31 (4)
RapaLink-1 (3)
AVTX-006 (2)
SBI-756 (2)
RMC-5552 (1)
SBI-726 (1)
WYE-125132 (0)
XP-105 (0)
AZD2014 (4)
Torin1 (2)
PP242 (2)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
MUC5B mutation
Lung Cancer
MUC5B mutation
Lung Cancer
ATG-008
Sensitive: D – Preclinical
ATG-008
Sensitive
:
D
ATG-008
Sensitive: D – Preclinical
ATG-008
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login